Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65-74 years from a population screening study (VIVA trial)

British Journal of Surgery

Volumn 102, Issue 8, 2015, Pages 902-906

  Grondal N ^a   Sogaard R ^b   Lindholt, J S ^a,c  

^a VIBORG HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTIC ANEURYSM, ABDOMINAL; DENMARK; EPIDEMIOLOGY; HUMANS; HYPERTENSION; MALE; MASS SCREENING; PERIPHERAL ARTERIAL DISEASE; PREVALENCE;

AGED; AORTIC ANEURYSM, ABDOMINAL; DENMARK; HUMANS; HYPERTENSION; MALE; MASS SCREENING; PERIPHERAL ARTERIAL DISEASE; PREVALENCE;

EID: 84931563383     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9825     Document Type: Article

References (21)

1. Giardina S, Pane B, Spinella G, Cafueri G, Corbo M, Brasseur P, etal. An economic evaluation of an abdominal aortic aneurysm screening program in Italy. J Vasc Surg 2011; 54: 938-946.
2. Søgaard R, Laustsen J, Lindholt J,. Cost effectiveness of abdominal aortic aneurysm screening and rescreening in men in a modern context: evaluation of a hypothetical cohort using a decision analytical model. BMJ 2012; 345: e4276.
3. Spronk S, van Kempen BJ, Boll AP, Jørgensen JJ, Hunink MG, Kristiansen IS,. Cost-effectiveness of screening for abdominal aortic aneurysm in the Netherlands and Norway. Br J Surg 2011; 98: 1546-1555.
4. Thompson S, Ashton H, Gao L, Scott RA,; Multicentre Aneurysm Screening Study Group. Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study. BMJ 2009; 338: b2307.
5. Diehm C, Kareem S, Lawall H,. Epidemiology of peripheral arterial disease. VASA 2004; 33: 183-189.
6. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, etal.; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2007; 28: 2375-2414.
7. McDermott M., The magnitude of the problem of peripheral arterial disease: epidemiology and clinical significance. Cleve Clin J Med 2006; 73 (Suppl 4): S2-S27.
8. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, etal. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl 1): S1-S75.
9. Barron S, Balanda K, Hughes J, Fahy L,. National and subnational hypertension prevalence estimates for the Republic of Ireland: better outcome and risk factor data are needed to produce better prevalence estimates. BMC Public Health 2014; 14: 24.
10. Grøndal N, Søgaard R, Henneberg E, Lindholt JS,. The Viborg Vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocol. Trials 2010; 11: 67.
11. Joensen JB, Juul S, Abrahamsen J, Henneberg EW, Lindholt JS,. Doppler ultrasound compared with strain gauge for measurement of systolic ankle blood pressure. Angiology 2008; 59: 296-300.
12. Lindholt JS, Juul S, Fasting H, Henneberg EW,. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ 2005; 330: 750.
13. Hager J, Länne T, Carlsson P, Lundgren F,. Lower prevalence than expected when screening 70-year-old men for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2013; 46: 453-459.
14. Darwood RJ, Brooks MJ,. The impact of decreasing abdominal aortic aneurysm prevalence on a local aneurysm screening programme. Eur J Vasc Endovasc Surg 2012; 44: 45-50.
15. Svensjö S, Björck M, Gürtelschmid M, Djavani Gidlund K, Hellberg A, Wanhainen A,. Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease. Circulation 2011; 124: 1118-1123.
16. Lindholt JS, Søgaard R, Laustsen J,. Prognosis of ruptured abdominal aortic aneurysms in Denmark from 1994-2008. Clin Epidemiol 2012; 4: 111-113.
17. Sidloff D, Stather P, Dattani N, Bown M, Thompson J, Sayers R, etal. Aneurysm global epidemiology study: public health measures can further reduce abdominal aortic aneurysm mortality. Circulation 2014; 129: 747-753.
18. Alzamora MT, Forés R, Baena-Díez JM, Pera G, Toran P, Sorribes M, etal. The peripheral arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population. BMC Public Health 2010; 10: 38.
19. Félix-Redondo FJ, Fernández-Bergés D, Grau M, Baena-Diez JM, Mostaza JM, Vila J,. Prevalence and clinical characteristics of peripheral arterial disease in the study population Hermex. Rev Esp Cardiol 2012; 65: 726-733.
20. Argyriou C, Saleptsis V, Koutsias S, Giannoukas AD,. Peripheral arterial disease is prevalent but underdiagnosed and undertreated in the primary care setting in central Greece. Angiology 2013; 64: 119-124.
21. Søgaard R, Lindholt J, Gyrd-Hansen D,. Individual decision making in relation to participation in cardiovascular screening: a study of revealed and stated preferences. Scand J Public Health 2013; 41: 43-50.